We are honored to announce our newest partnership between M2030 and the Myanmar Red Cross Society (MRCS). MRCS is one of the country’s leading humanitarian organization, working tirelessly to develop safe and resilient communities amongst the country’s most vulnerable populations. We are excited to be working with this prestigious organization in the fight to eliminate malaria in Myanmar by 2030!
Nan Kham Lee (20) a young CESVI malaria volunteer who looks after community members in her village. Since she began in 2006, she’s cared for 45 malaria patients, among 93 households in the village. She’s been a volunteer for 6 years, since she was 14 years old. Last 2 years 6 malaria patients and last one year, 2 patients. She had a patient come to visit her from his remote farm last week; diagnosed him with plasmodium vivax. He was given treatment and returned back to his farm, a 3 hour walk. Nan Kham Lee was trained at Kyauk Me Township hospital. She attended school to 7th standard, but could not afford to continue school when her mother suffered breast cancer. It was at this point that she transitioned to malaria volunteer training. Two years ago her father suffered a high fever while working at his farm which is a distance away from this village (45 mins walk). Some of the men working with him came to tell her he was ill. Although her father was very frightened, Nan Kham Lee wasn’t scared; she felt confident she’d be able to help him. While he was ill her father told her he would die soon, and just wanted to see her and the family one last time. When he was cured, her father said he was so lucky to have a daughter like that; he was grateful for the medicine and to his daughter, as well as the organization that trained her. For her part she felt glad that she could save her father’s life. She’s pleased to work as a volunteer health worker because before, villagers had to travel far to seek treatment if they fell ill. Most people couldn’t afford it so they couldn’t get relief from their illness. Photo credit: The Global Fund | John Rae